Discontinued — last reported Q4 '23

Equity

Common Stock Shares Outstanding

Merck & Co. Common Stock Shares Outstanding increased by 10.4% to $275.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.4%, from $249.00M to $275.00M. Over 5 years (FY 2020 to FY 2025), Common Stock Shares Outstanding shows a downward trend with a -4.9% CAGR.

Analysis

StatementBalance Sheet Statement
SectionEquity
First reportedQ4 2015
Last reportedQ4 2023
Metric ID: common_stock_shares_outstanding

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$213.00M$554.00M$442.00M$249.00M$275.00M
QoQ Change—+160.1%-20.2%-43.7%+10.4%
YoY Change—+160.1%-20.2%-43.7%+10.4%
Range$213.00M – $554.00M
CAGR+29.1%
Avg YoY Growth+26.7%
Median YoY Growth-4.9%

Frequently Asked Questions

What is Merck & Co.'s common stock shares outstanding?
Merck & Co. (MRK) reported common stock shares outstanding of $275.00M in Q4 2025.
How has Merck & Co.'s common stock shares outstanding changed year-over-year?
Merck & Co.'s common stock shares outstanding increased by 10.4% year-over-year, from $249.00M to $275.00M.
What is the long-term trend for Merck & Co.'s common stock shares outstanding?
Over 5 years (2020 to 2025), Merck & Co.'s common stock shares outstanding has grown at a -4.9% compound annual growth rate (CAGR), from $353.00M to $275.00M.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.